Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Household economic costs associated with mental, neurological and substance use disorders: a cross-sectional survey in six low- and middle-income countries.

Lund C, Docrat S, Abdulmalik J, Alem A, Fekadu A, Gureje O, Gurung D, Hailemariam D, Hailemichael Y, Hanlon C, Jordans MJD, Kizza D, Nanda S, Olayiwola S, Shidhaye R, Upadhaya N, Thornicroft G, Chisholm D.

BJPsych Open. 2019 Apr 8;5(3):e34. doi: 10.1192/bjo.2019.20.

2.

Mental health problems and socioeconomic disadvantage: a controlled household study in rural Ethiopia.

Hailemichael Y, Hanlon C, Tirfessa K, Docrat S, Alem A, Medhin G, Fekadu A, Lund C, Chisholm D, Hailemariam D.

Int J Equity Health. 2019 Jul 31;18(1):121. doi: 10.1186/s12939-019-1020-4.

3.

Catastrophic health expenditure and impoverishment in households of persons with depression: a cross-sectional, comparative study in rural Ethiopia.

Hailemichael Y, Hanlon C, Tirfessa K, Docrat S, Alem A, Medhin G, Lund C, Chisholm D, Fekadu A, Hailemariam D.

BMC Public Health. 2019 Jul 11;19(1):930. doi: 10.1186/s12889-019-7239-6.

4.

Catastrophic out-of-pocket payments for households of people with severe mental disorder: a comparative study in rural Ethiopia.

Hailemichael Y, Hailemariam D, Tirfessa K, Docrat S, Alem A, Medhin G, Lund C, Chisholm D, Fekadu A, Hanlon C.

Int J Ment Health Syst. 2019 Jun 1;13:39. doi: 10.1186/s13033-019-0294-7. eCollection 2019.

5.

Food insecurity and work impairment in people with severe mental disorders in a rural district of Ethiopia: a cross-sectional survey.

Tirfessa K, Lund C, Medhin G, Hailemichael Y, Habtamu K, Fekadu A, Hanlon C.

Soc Psychiatry Psychiatr Epidemiol. 2019 Sep;54(9):1055-1066. doi: 10.1007/s00127-019-01709-7. Epub 2019 Apr 19.

PMID:
31004179
6.

Vaccinating with Stem Cells to Stop Cancer.

Hailemichael Y, Singh M, Overwijk W.

Trends Mol Med. 2018 Jun;24(6):524-526. doi: 10.1016/j.molmed.2018.04.006. Epub 2018 May 3.

PMID:
29731352
7.

Factors and misperceptions of routine childhood immunization service uptake in Ethiopia: findings from a nationwide qualitative study.

Tadesse T, Getachew K, Assefa T, Ababu Y, Simireta T, Birhanu Z, Hailemichael Y.

Pan Afr Med J. 2017 Dec 5;28:290. doi: 10.11604/pamj.2017.28.290.14133. eCollection 2017.

8.

Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response.

Khong H, Volmari A, Sharma M, Dai Z, Imo CS, Hailemichael Y, Singh M, Moore DT, Xiao Z, Huang XF, Horvath TD, Hawke DH, Overwijk WW.

J Immunol. 2018 May 15;200(10):3464-3474. doi: 10.4049/jimmunol.1700467. Epub 2018 Apr 11.

9.

Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma.

Zhang X, Lee HC, Shirazi F, Baladandayuthapani V, Lin H, Kuiatse I, Wang H, Jones RJ, Berkova Z, Singh RK, Lu J, Qian Y, Raina K, Coleman KG, Crews CM, Li B, Wang H, Hailemichael Y, Thomas SK, Wang Z, Davis RE, Orlowski RZ.

Leukemia. 2018 Oct;32(10):2224-2239. doi: 10.1038/s41375-018-0044-x. Epub 2018 Mar 27.

10.

Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy.

Hailemichael Y, Woods A, Fu T, He Q, Nielsen MC, Hasan F, Roszik J, Xiao Z, Vianden C, Khong H, Singh M, Sharma M, Faak F, Moore D, Dai Z, Anthony SM, Schluns KS, Sharma P, Engelhard VH, Overwijk WW.

J Clin Invest. 2018 Apr 2;128(4):1338-1354. doi: 10.1172/JCI93303. Epub 2018 Feb 26.

11.

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model.

Haymaker CL, Hailemichael Y, Yang Y, Nurieva R.

J Vis Exp. 2017 Nov 28;(129). doi: 10.3791/56255.

12.

Food insecurity among people with severe mental disorder in a rural Ethiopian setting: a comparative, population-based study.

Tirfessa K, Lund C, Medhin G, Hailemichael Y, Fekadu A, Hanlon C.

Epidemiol Psychiatr Sci. 2019 Aug;28(4):397-407. doi: 10.1017/S2045796017000701. Epub 2017 Nov 16.

PMID:
29143723
13.

Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.

Singh M, Vianden C, Cantwell MJ, Dai Z, Xiao Z, Sharma M, Khong H, Jaiswal AR, Faak F, Hailemichael Y, Janssen LME, Bharadwaj U, Curran MA, Diab A, Bassett RL, Tweardy DJ, Hwu P, Overwijk WW.

Nat Commun. 2017 Nov 13;8(1):1447. doi: 10.1038/s41467-017-01572-7.

14.

Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.

Dalton HJ, Pradeep S, McGuire M, Hailemichael Y, Ma S, Lyons Y, Armaiz-Pena GN, Previs RA, Hansen JM, Rupaimoole R, Gonzalez-Villasana V, Cho MS, Wu SY, Mangala LS, Jennings NB, Hu W, Langley R, Mu H, Andreeff M, Bar-Eli M, Overwijk W, Ram P, Lopez-Berestein G, Coleman RL, Sood AK.

Clin Cancer Res. 2017 Nov 15;23(22):7034-7046. doi: 10.1158/1078-0432.CCR-17-0647. Epub 2017 Aug 29.

15.

Absence of Grail promotes CD8+ T cell anti-tumour activity.

Haymaker C, Yang Y, Wang J, Zou Q, Sahoo A, Alekseev A, Singh D, Ritthipichai K, Hailemichael Y, Hoang ON, Qin H, Schluns KS, Wang T, Overwijk WW, Sun SC, Bernatchez C, Kwak LW, Neelapu SS, Nurieva R.

Nat Commun. 2017 Aug 10;8(1):239. doi: 10.1038/s41467-017-00252-w.

16.

Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.

Ritthipichai K, Haymaker CL, Martinez M, Aschenbrenner A, Yi X, Zhang M, Kale C, Vence LM, Roszik J, Hailemichael Y, Overwijk WW, Varadarajan N, Nurieva R, Radvanyi LG, Hwu P, Bernatchez C.

Clin Cancer Res. 2017 Oct 15;23(20):6151-6164. doi: 10.1158/1078-0432.CCR-16-1217. Epub 2017 Jul 28.

17.

Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways.

Anthony SM, Howard ME, Hailemichael Y, Overwijk WW, Schluns KS.

PLoS One. 2015 Mar 10;10(3):e0120274. doi: 10.1371/journal.pone.0120274. eCollection 2015.

18.

Mouse model for pre-clinical study of human cancer immunotherapy.

Ya Z, Hailemichael Y, Overwijk W, Restifo NP.

Curr Protoc Immunol. 2015 Feb 2;108:20.1.1-43. doi: 10.1002/0471142735.im2001s108.

19.

Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice.

Qin H, Lerman B, Sakamaki I, Wei G, Cha SC, Rao SS, Qian J, Hailemichael Y, Nurieva R, Dwyer KC, Roth J, Yi Q, Overwijk WW, Kwak LW.

Nat Med. 2014 Jun;20(6):676-81. doi: 10.1038/nm.3560. Epub 2014 May 25.

20.

Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.

Hailemichael Y, Overwijk WW.

Int J Biochem Cell Biol. 2014 Aug;53:46-50. doi: 10.1016/j.biocel.2014.04.019. Epub 2014 May 2. Review.

21.

Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyard.

Hailemichael Y, Overwijk WW.

Oncoimmunology. 2013 Jul 1;2(7):e24743. Epub 2013 Apr 30.

22.

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.

Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, Dorta-Estremera SM, Greeley NR, Nitti G, Peng W, Liu C, Lou Y, Wang Z, Ma W, Rabinovich B, Sowell RT, Schluns KS, Davis RE, Hwu P, Overwijk WW.

Nat Med. 2013 Apr;19(4):465-72. doi: 10.1038/nm.3105. Epub 2013 Mar 3.

23.

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release.

Jayaraman P, Parikh F, Lopez-Rivera E, Hailemichael Y, Clark A, Ma G, Cannan D, Ramacher M, Kato M, Overwijk WW, Chen SH, Umansky VY, Sikora AG.

J Immunol. 2012 Jun 1;188(11):5365-76. doi: 10.4049/jimmunol.1103553. Epub 2012 Apr 23.

24.

Conference scene: immune effector mechanisms in tumor immunity.

Sikora AG, Hailemichael Y, Overwijk WW.

Immunotherapy. 2012 Feb;4(2):141-3. doi: 10.2217/imt.11.177.

25.
26.

Antitumor activity mediated by CpG: the route of administration is critical.

Lou Y, Liu C, Lizée G, Peng W, Xu C, Ye Y, Rabinovich BA, Hailemichael Y, Gelbard A, Zhou D, Overwijk WW, Hwu P.

J Immunother. 2011 Apr;34(3):279-88. doi: 10.1097/CJI.0b013e31820d2a05.

27.

The synergy between TB and HIV co-infection on perceived stigma in Ethiopia.

Deribew A, Hailemichael Y, Tesfaye M, Desalegn D, Wogi A, Daba S.

BMC Res Notes. 2010 Oct 4;3:249. doi: 10.1186/1756-0500-3-249.

28.

Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB.

Clin Cancer Res. 2010 May 1;16(9):2550-61. doi: 10.1158/1078-0432.CCR-10-0279. Epub 2010 Apr 13.

29.

Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy.

Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, Overwijk WW.

Clin Cancer Res. 2010 Mar 15;16(6):1834-44. doi: 10.1158/1078-0432.CCR-09-3123. Epub 2010 Mar 9.

30.

Health workforce deployment, attrition and density in East wollega zone, Western ethiopia.

Hailemichael Y, Jira C, Girma B, Tushune K.

Ethiop J Health Sci. 2010 Mar;20(1):15-23.

31.

IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.

Sikora AG, Jaffarzad N, Hailemichael Y, Gelbard A, Stonier SW, Schluns KS, Frasca L, Lou Y, Liu C, Andersson HA, Hwu P, Overwijk WW.

J Immunol. 2009 Jun 15;182(12):7398-407. doi: 10.4049/jimmunol.0802982.

32.

Resource allocation and bionomics of indigenous and exotic Cotesia (Hymenoptera: Braconidae) species reared on Sesamia calamistis.

Hailemichael Y, Schulthess F, Smith J, Overholt W, Chabi-Olaye A.

Bull Entomol Res. 2008 Aug;98(4):405-15. doi: 10.1017/S0007485308005725. Epub 2008 Feb 25.

PMID:
18294415

Supplemental Content

Loading ...
Support Center